Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-003403
Filing Date
2025-04-09
Accepted
2025-04-09 16:05:51
Documents
10

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 369536
2 ex5-1.htm EX-5.1 9860
3 ex23-1.htm EX-23.1 2433
4 CALCULATION OF FILING FEE TABLE ex107.htm EX-FILING FEES 18058
5 forms-1_001.jpg GRAPHIC 26425
6 forms-1_002.jpg GRAPHIC 38678
7 forms-1_003.jpg GRAPHIC 40636
8 forms-1_004.jpg GRAPHIC 39567
9 ex5-1_001.jpg GRAPHIC 10394
10 ex5-1_002.jpg GRAPHIC 4679
  Complete submission text file 0001641172-25-003403.txt   622559
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-286385 | Film No.: 25825235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)